BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1575009)

  • 1. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
    Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
    Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of cerebrospinal fluid beta 2-microglobulin determination in central nervous system leukemia].
    Zhang HZ; Ye X; Sun ZG
    Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):262-4, 313. PubMed ID: 2680338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination.
    Mavlight GM; Stuckey SE; Cabanillas FF; Keating MJ; Tourtellotte WW; Schold SC; Freireich EJ
    N Engl J Med; 1980 Sep; 303(13):718-22. PubMed ID: 6157089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta 2-microglobulin levels in cerebrospinal fluid of children with leukemia and lymphoma.
    Pudek MR; Chan KW; Rogers PC; Teasdale JM
    Clin Biochem; 1985 Jun; 18(3):180-3. PubMed ID: 3888445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia.
    Weller M; Stevens A; Sommer N; Schabet M; Wiethölter H
    Acta Neurol Scand; 1992 Aug; 86(2):129-33. PubMed ID: 1414221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid beta-2-microglobulin level as marker of central nervous system involvement in lymphoma.
    Pagano L; Marra R; Storti S; De Stefano V; Bizzi B
    Haematologia (Budap); 1986; 19(2):121-5. PubMed ID: 3530906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy.
    Jeffery GM; Frampton CM; Legge HM; Hart DN
    Pathology; 1990 Jan; 22(1):20-3. PubMed ID: 2194155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 2-microglobulin, lysozyme and lactoferrin in cerebrospinal fluid in patients with lymphoma or leukaemia: relationship to CNS involvement and the effect of prophylactic intrathecal treatment with methotrexate.
    Oberg G; Hällgren R; Venge P
    Br J Haematol; 1987 Jul; 66(3):315-22. PubMed ID: 3304392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid beta-2-microglobulin: a reliable index of leukaemic infiltration of central nervous system.
    Storti S; Pagano L; Marra R; Teofili L; Ricerca BM; Leone G; Bizzi B
    Scand J Haematol; 1986 Oct; 37(4):301-5. PubMed ID: 3538368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
    Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
    Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of central nervous system metastasis with cerebrospinal fluid beta-2-microglobulin.
    Koch TR; Lichtenfeld KM; Wiernik PH
    Cancer; 1983 Jul; 52(1):101-4. PubMed ID: 6189578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
    Lossos IS; Breuer R; Intrator O; Lossos A
    Cancer; 2000 Apr; 88(7):1599-604. PubMed ID: 10738218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies.
    Kara IO; Sahin B; Gunesacar R
    Adv Ther; 2007; 24(4):741-7. PubMed ID: 17901023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid neopterin levels in children with central nervous system leukemia.
    Millot F; Dhondt JL; Mazingue F; Mechinaud F; Auget JL; Bauters F; Harousseau JL
    Leuk Lymphoma; 1993 Mar; 9(4-5):351-6. PubMed ID: 8348070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system relapse surveillance by serial beta 2-microglobulin measurements in childhood acute lymphoblastic leukemia.
    Clausen N; Ibsen KK
    Acta Paediatr Scand; 1984 Nov; 73(6):848-54. PubMed ID: 6395626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancy markers in the cerebrospinal fluid.
    Koskiniemi M
    Eur J Pediatr; 1988 Oct; 148(1):3-8. PubMed ID: 3058481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma.
    Chang CS; Liu HW; Lin SF; Chen TP
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):132-7. PubMed ID: 2605973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminal deoxynucleotidyl transferase (TdT)-positive cells in cerebrospinal fluid and development of overt CNS leukemia: a 5-year follow-up study in 113 children with a TdT-positive leukemia or non-Hodgkin's lymphoma.
    Hooijkaas H; Hählen K; Adriaansen HJ; Dekker I; van Zanen GE; van Dongen JJ
    Blood; 1989 Jul; 74(1):416-22. PubMed ID: 2752121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of cerebrospinal fluid sialic acid concentration in children with central nervous system leukemia.
    Asami T; Tanaka A; Gunji T; Sakai K; Asami K
    Acta Paediatr Scand; 1987 Mar; 76(2):260-5. PubMed ID: 3296627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia.
    Müller HL; Oh Y; Lehrnbecher T; Blum WF; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Aug; 79(2):428-34. PubMed ID: 7519190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.